Lung cancer rates lower at higher elevations
the ONA take:
According to a new study published in the journal Peerj, researchers from the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, and the University of California Department of Biological and Medical Informatics in San Francisco, California, have found that lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
For the study, the researchers sought to investigate whether inhaled oxygen could be a carcinogen by analyzing cancer incidence rates across the Western United States.
They found that as the county elevation increased, lung cancer rates decreased. Specifically, lung cancer incidence decreased by 7.23 cases per 100,000 individuals for every 1,000-meter elevation increasing. The researchers accounted for various variables, such as smoking prevalence and education.
The authors note, however, that the observed association does not prove a causal effect between oxygen and lung cancer. They also evaluated rates of breast, colorectal, and prostate cancer, and found a weak association or no association between elevation and incidence.
The findings will probably not persuade individuals to relocate, but the identification of a universal and major risk factor for lung cancer may lead to better treatments and preventative approaches.
Lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|